Jenny Karlsson

Jenny Karlsson

Company: Bayer

Job title: Head of TRP Biochemistry


14 years industrial experience of research and development of antibody-based therapies, protein engineering and conjugation technologies, with a PhD in Biochemistry from Göteborgs University. Currently at the Targeted Radiopharmaceutical department, Bayer AS, focusing on targeted alpha therapy (TAT) with three targeted thorium conjugates (TTCs) in clinical Phase I.

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.